PRESS RELEASE

PRESS RELEASE

View printer-friendly version << Back

U.S. Senator Rick Santorum (R-PA) Will Tour Novavax Facility

MALVERN, Pa., March 9 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that United States Senator Rick Santorum (R-PA), Chairman of the Senate Republican Conference, will personally visit the Novavax Headquarters on Friday morning, March 10, 2006, located at 508 Lapp Road, Malvern, PA.

Senator Santorum plans on touring the Novavax facility, host a Town Hall Meeting, and meet with Company management and employees.

For more information about Senator Santorum go to http://santorum.senate.gov

About Novavax, Inc.

Novavax is focused on creating differentiated, value-added pharmaceutical and vaccine products and technologies. The company's technology platforms include the virus-like particle (VLP) manufacturing technology utilizing the baculovirus expression system in insect cells, as well as novel vaccine adjuvants based on Novasomes and dendrimer technologies. The company is developing vaccine against the H5N1 strain of avian influenza virus and the human seasonal influenza virus using its VLP and Novasome technologies. Novavax's drug delivery technologies include the micellar nanoparticle (MNP) technology which is the basis for the development of its first FDA-approved product, ESTRASORB. In addition to MNP, Novavax drug delivery technologies include Novasomes(R) (paucillamellar non-phospholipid vesicles) and Sterisomes(R) (subcutaneous depot injection). The company has several products utilizing the MNP technology in various stages of development.

SOURCE Novavax, Inc.

CONTACT: Investor Relations, Kathy Hamilton of Novavax, Inc., +1-484-913-1213, or
khamilton@novavax.com